OTCMKTS:BXRXV Baudax Bio (BXRXV) Stock Price, News & Analysis → Bigger Than NVIDIA? (From Behind the Markets) (Ad) Free BXRXV Stock Alerts $4.51 -1.00 (-18.15%) (As of 11/21/2019) Add Compare Share Share Today's Range$4.51▼$5.5250-Day Range$4.51▼$4.5152-Week Range$4.51▼$9.00Volume119,000 shsAverage Volume53,220 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get Baudax Bio alerts: Email Address Ad InvestorPlaceJeff Bezos & 48 Members of Congress Are Buying ONE Sector…Why are Warren Buffett, Jeff Bezos, Michael Bloomberg, “The Walmart Family”, Bill Gates, and 48 members of Congress shifting their stocks in a frenzy? And why are they all piling into ONE unique corner of the market…Click here for the details About Baudax Bio Stock (OTCMKTS:BXRXV)Read More BXRXV Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BXRXV Stock News HeadlinesJune 11, 2024 | americanbankingnews.comBaudax Bio (OTCMKTS:BXRXV) Trading Down 18.1%April 24, 2024 | investing.comBaudax Bio Inc (BXRXQ)March 20, 2024 | morningstar.comBaudax Bio Inc Ordinary Shares BXRXQSeptember 28, 2023 | stockhouse.comBaudax Bio Announces Orphan Drug Designation Granted by U.S. FDA for TI-168 for the Treatment of Hemophilia A with InhibitorsAugust 23, 2023 | markets.businessinsider.comNoble Financial Remains a Hold on Baudax Bio (BXRX)June 30, 2023 | msn.comWhat's Happening With Baudax Bio Shares TodayJune 30, 2023 | msn.comBaudax Bio Soars on Snapping Up Cell Therapy Developer TeraImmuneJune 30, 2023 | finance.yahoo.comBaudax Bio Acquires TeraImmune, Inc.June 7, 2023 | benzinga.comBaudax Bio Touts Additional Positive Data From Nerve Blocker In Surgery PatientsJune 7, 2023 | technews.tmcnet.comBaudax Bio Announces Additional, Positive Top-Line Results From Phase 2 Randomized Clinical Trial of BX1000June 6, 2023 | finance.yahoo.comBaudax Bio Announces Date of Reconvened Annual MeetingApril 27, 2023 | finanznachrichten.deBaudax Bio, Inc.: Baudax Bio Announces Pricing of $4 Million Public OfferingApril 27, 2023 | msn.comBaudax Bio stock dips on pricing $4M stock offering at $1.15/shareApril 25, 2023 | finance.yahoo.comBaudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000March 27, 2023 | finance.yahoo.comBaudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000January 24, 2023 | finance.yahoo.comWhy Baudax Bio Shares Trading Higher TodayJanuary 24, 2023 | finance.yahoo.comBaudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000January 14, 2023 | seekingalpha.comBXRX Baudax Bio, Inc.December 8, 2022 | finance.yahoo.comBaudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing SurgeryDecember 6, 2022 | nz.finance.yahoo.comBaudax Bio Announces Closing of $5 Million Public OfferingDecember 3, 2022 | finanznachrichten.deBaudax Bio, Inc.: Baudax Bio Announces Pricing of $5 Million Public OfferingDecember 2, 2022 | nz.finance.yahoo.comBaudax Bio Announces Pricing of $5 Million Public OfferingNovember 30, 2022 | yahoo.comBaudax Bio Announces 1-for-40 Reverse Stock SplitNovember 8, 2022 | msn.comBaudax Bio, Inc. (BXRX) Reports Q3 Loss, Lags Revenue EstimatesSeptember 1, 2022 | benzinga.comBaudax Bio Announces Closing of $6.2 Million Public OfferingSee More Headlines Receive BXRXV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Baudax Bio and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTCMKTS:BXRXV CUSIPN/A CIKN/A Webwww.baudaxbio.com PhoneN/AFaxN/AEmployees20Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 5G Stocks: The Path Forward is ProfitableClick the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise. Get This Free Report Key Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors BXRXV Stock Analysis - Frequently Asked Questions How have BXRXV shares performed in 2024? Baudax Bio's stock was trading at $4.51 at the start of the year. Since then, BXRXV stock has increased by 0.0% and is now trading at $4.51. View the best growth stocks for 2024 here. How do I buy shares of Baudax Bio? Shares of BXRXV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BXRXV) was last updated on 6/17/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBigger Than NVIDIA?With NVIDIA flying high, everyone is looking for the next breakout stock. But right now... There's only ...Behind the Markets | SponsoredThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredHow Biden has already won 2024Obama’s Forever Term [Exposed] or Obama Biden has already won 2024 Exposed: the shocking election plot that...Porter & Company | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | SponsoredWho are Nvidia’s Silent Partners?Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.Weiss Ratings | SponsoredBuy this small stock before coming AI Tidal WaveThe internet generated more wealth than any other innovation in history - creating hundreds of thousands of ne...Chaikin Analytics | SponsoredBiden Nomination CANCELED?And I believe when they do take the oath of office, their fingers will be crossed… and America will descend in...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Baudax Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Baudax Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
